Drug & intervention

Entresto

RxCUI 1656341

Clinical trials7

Recruiting0

Related conditions6

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

7 shown

Special Drug Use Surveillance of Entresto Tablets (Hypertension)NCT05976230 · 2023-09-04

Special Drug Use Surveillance for Entresto TabletsNCT04781881 · 2021-03-04

Effect of Neprilysin on Glucagon-Like Peptide-1 in Patients With Type 2 DiabetesNCT03893526 · 2019-01-25

Effect of Angiotensin-Neprilysin Inhibition (ARNI) on Prognosis of Chronic Heart FailureNCT03821701 · 2018-06-01

The Effects of Neprilysin on Glucagon-like Peptide-1NCT03717688 · 2018-05-17

Sacubitril-valsartan Versus Usual Anti-hypertensives in LVADNCT03279861 · 2017-11-01

Demonstration of Reverse Remodeling Effects of Entresto. Using Echocardiography Endocardial Surface AnalysisNCT02754518 · 2016-04-01

Conditions being studied

Chronic Heart Failure2 Heart Failure2 Hypertension2 Congestive Heart Failure1 Diabetes1 Type2 Diabetes1

Research locations

NagoyaAichi-ken, Japan2 SapporoHokkaido, Japan2 YokohamaKanagawa, Japan2 ChicagoIllinois, United States1 CopenhagenDenmark1 FukuokaJapan1 HiroshimaJapan1 KyotoJapan1 OsakaJapan1 Xi'anShaanxi, China1

Leading sponsors

Novartis Pharmaceuticals2 First Affiliated Hospital Xi'an Jiaotong University1 Nicolai Jacob Wewer Albrechtsen1 University of Chicago1 University of Copenhagen1 University of Maryland, Baltimore1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.